Federal Register / Vol. 89, No. 193 / Friday, October 4, 2024 / Notices 80929 

authorized representative identified in 

this notice under ADDRESSES. Requests 

for repatriation may be submitted by: 

1. Any one or more of the Indian 

Tribes or Native Hawaiian organizations 

identified in this notice. 

2. Any lineal descendant, Indian 

Tribe, or Native Hawaiian organization 

not identified in this notice who shows, 

by a preponderance of the evidence, that 

the requestor is a lineal descendant or 

a culturally affiliated Indian Tribe or 

Native Hawaiian organization. 

Repatriation of the human remains 

and associated funerary objects in this 

notice to a requestor may occur on or 

after November 4, 2024. If competing 

requests for repatriation are received, 

the California Department of Parks and 

Recreation and the California 

Department of Water Resources must 

determine the most appropriate 

requestor prior to repatriation. Requests 

for joint repatriation of the human 

remains and associated funerary objects 

are considered a single request and not 

competing requests. The California 

Department of Parks and Recreation and 

the California Department of Water 

Resources are responsible for sending a 

copy of this notice to the Indian Tribes 

and Native Hawaiian organizations 

identified in this notice. 

Authority: Native American Graves 

Protection and Repatriation Act, 25 

U.S.C. 3003, and the implementing 

regulations, 43 CFR 10.10. 

Dated: September 25, 2024. 

Melanie O’Brien, 

Manager, National NAGPRA Program. 

[FR Doc. 2024–22888 Filed 10–3–24; 8:45 am] 

BILLING CODE 4312–52–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation Nos. 701–TA–737–738 and 

731–TA–1712–1715 (Preliminary)] 

Hexamine (Hexamethylenetetramine) 

From China, Germany, India, and Saudi 

Arabia; Notice of Institution of 

Antidumping and Countervailing Duty 

Investigations and Scheduling of 

Preliminary Phase Investigations 

AGENCY: United States International 

Trade Commission. 

ACTION: Notice. 

SUMMARY: The Commission hereby gives 

notice of the institution of investigations 

and commencement of preliminary 

phase antidumping and countervailing 

duty investigation Nos. 701–TA–737– 

738 and 731–TA–1712–1715 

(Preliminary) pursuant to the Tariff Act 

of 1930 (‘‘the Act’’) to determine 

whether there is a reasonable indication 

that an industry in the United States is 

materially injured or threatened with 

material injury, or the establishment of 

an industry in the United States is 

materially retarded, by reason of 

imports of hexamine 

(hexamethylenetetramine) from China, 

Germany, India, and Saudi Arabia, 

provided for in subheading 2933.69.50 

of the Harmonized Tariff Schedule of 

the United States, that are alleged to be 

sold in the United States at less than fair 

value and alleged to be subsidized by 

the governments of China and India. 

Unless the Department of Commerce 

(‘‘Commerce’’) extends the time for 

initiation, the Commission must reach a 

preliminary determination in 

antidumping and countervailing duty 

investigations in 45 days, or in this case 

by November 14, 2024. The 

Commission’s views must be 

transmitted to Commerce within five 

business days thereafter, or by 

November 21, 2024. 

DATES: September 30, 2024. 

FOR FURTHER INFORMATION CONTACT: 

Charles Cummings (708–1666), Office of 

Investigations, U.S. International Trade 

Commission, 500 E Street SW, 

Washington, DC 20436. Hearingimpaired persons can obtain 

information on this matter by contacting 

the Commission’s TDD terminal on 202– 

205–1810. Persons with mobility 

impairments who will need special 

assistance in gaining access to the 

Commission should contact the Office 

of the Secretary at 202–205–2000. 

General information concerning the 

Commission may also be obtained by 

accessing its internet server (https://

www.usitc.gov). The public record for 

these investigations may be viewed on 

the Commission’s electronic docket 

(EDIS) at https://edis.usitc.gov. 

SUPPLEMENTARY INFORMATION: 

Background.—These investigations 

are being instituted, pursuant to 

sections 703(a) and 733(a) of the Tariff 

Act of 1930 (19 U.S.C. 1671b(a) and 

1673b(a)), in response to petitions filed 

on September 30, 2024, by Bakelite 

Synthetics, Atlanta, Georgia. 

For further information concerning 

the conduct of these investigations and 

rules of general application, consult the 

Commission’s Rules of Practice and 

Procedure, part 201, subparts A and B 

(19 CFR part 201), and part 207, 

subparts A and B (19 CFR part 207). 

Participation in the investigations and 

public service list.—Persons (other than 

petitioners) wishing to participate in the 

investigations as parties must file an 

entry of appearance with the Secretary 

to the Commission, as provided in 

§§ 201.11 and 207.10 of the 

Commission’s rules, not later than seven 

days after publication of this notice in 

the Federal Register. Industrial users 

and (if the merchandise under 

investigation is sold at the retail level) 

representative consumer organizations 

have the right to appear as parties in 

Commission antidumping duty and 

countervailing duty investigations. The 

Secretary will prepare a public service 

list containing the names and addresses 

of all persons, or their representatives, 

who are parties to these investigations 

upon the expiration of the period for 

filing entries of appearance. 

Limited disclosure of business 

proprietary information (BPI) under an 

administrative protective order (APO) 

and BPI service list.—Pursuant to 

§ 207.7(a) of the Commission’s rules, the 

Secretary will make BPI gathered in 

these investigations available to 

authorized applicants representing 

interested parties (as defined in 19 

U.S.C. 1677(9)) who are parties to the 

investigations under the APO issued in 

the investigations, provided that the 

application is made not later than seven 

days after the publication of this notice 

in the Federal Register. A separate 

service list will be maintained by the 

Secretary for those parties authorized to 

receive BPI under the APO. 

Conference.—The Office of 

Investigations will hold a staff 

conference in connection with the 

preliminary phase of these 

investigations beginning at 9:30 a.m. on 

October 21, 2024. Requests to appear at 

the conference should be emailed to 

preliminaryconferences@usitc.gov (DO 

NOT FILE ON EDIS) on or before 5:15 

p.m. on October 17, 2024. Please 

provide an email address for each 

conference participant in the email. 

Information on conference procedures, 

format, and participation, including 

guidance for requests to appear as a 

witness via videoconference, will be 

available on the Commission’s Public 

Calendar (Calendar (USITC) | United 

States International Trade Commission). 

A nonparty who has testimony that may 

aid the Commission’s deliberations may 

request permission to participate by 

submitting a short statement. 

Please note the Secretary’s Office will 

accept only electronic filings during this 

time. Filings must be made through the 

Commission’s Electronic Document 

Information System (EDIS, https://edis.

usitc.gov). No in-person paper-based 

filings or paper copies of any electronic 

filings will be accepted until further 

notice. 

Written submissions.—As provided in 

§§ 201.8 and 207.15 of the 

Commission’s rules, any person may 


khammond on DSKJM1Z7X2PROD with NOTICES
80930 Federal Register / Vol. 89, No. 193 / Friday, October 4, 2024 / Notices 

submit to the Commission on or before 

5:15 p.m. on October 24, 2024, a written 

brief containing information and 

arguments pertinent to the subject 

matter of the investigations. Parties shall 

file written testimony and 

supplementary material in connection 

with their presentation at the conference 

no later than noon on October 18, 2024. 

All written submissions must conform 

with the provisions of § 201.8 of the 

Commission’s rules; any submissions 

that contain BPI must also conform with 

the requirements of §§ 201.6, 207.3, and 

207.7 of the Commission’s rules. The 

Commission’s Handbook on Filing 

Procedures, available on the 

Commission’s website at https://

www.usitc.gov/documents/handbook_

on_filing_procedures.pdf, elaborates 

upon the Commission’s procedures with 

respect to filings. 

In accordance with §§ 201.16(c) and 

207.3 of the rules, each document filed 

by a party to the investigations must be 

served on all other parties to the 

investigations (as identified by either 

the public or BPI service list), and a 

certificate of service must be timely 

filed. The Secretary will not accept a 

document for filing without a certificate 

of service. 

Certification.—Pursuant to § 207.3 of 

the Commission’s rules, any person 

submitting information to the 

Commission in connection with these 

investigations must certify that the 

information is accurate and complete to 

the best of the submitter’s knowledge. In 

making the certification, the submitter 

will acknowledge that any information 

that it submits to the Commission 

during these investigations may be 

disclosed to and used: (i) by the 

Commission, its employees and Offices, 

and contract personnel (a) for 

developing or maintaining the records 

of these or related investigations or 

reviews, or (b) in internal investigations, 

audits, reviews, and evaluations relating 

to the programs, personnel, and 

operations of the Commission including 

under 5 U.S.C. Appendix 3; or (ii) by 

U.S. government employees and 

contract personnel, solely for 

cybersecurity purposes. All contract 

personnel will sign appropriate 

nondisclosure agreements. 

Authority: These investigations are 

being conducted under authority of title 

VII of the Tariff Act of 1930; this notice 

is published pursuant to § 207.12 of the 

Commission’s rules. 

By order of the Commission. 

Issued: September 30, 2024. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2024–22956 Filed 10–3–24; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–1364] 

Certain Blood Flow Restriction Devices 

With Rotatable Windlasses and 

Components Thereof; Notice of 

Issuance of a General Exclusion Order, 

a Limited Exclusion Order, and Cease 

and Desist Orders; Termination of the 

Investigation 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the U.S. International Trade 

Commission (‘‘Commission’’) has 

determined to issue a general exclusion 

order (‘‘GEO’’) prohibiting the 

importation of blood flow restriction 

devices with rotatable windlasses and 

components thereof that infringe one or 

more of claims 1, 4, 15, or 16 of U.S. 

Patent No. 7,842,067 (‘‘the ’067 patent’’); 

a limited exclusion order (‘‘LEO’’) 

prohibiting the unlicensed entry of 

blood flow restriction devices with 

rotatable windlasses and components 

thereof that infringe the asserted 

trademarks and trade dress that are 

manufactured by or on behalf of, or 

imported by or on behalf of defaulting 

respondents; and cease and desist 

orders (‘‘CDOs’’) directed against certain 

defaulting respondents. The 

investigation is terminated. 

FOR FURTHER INFORMATION CONTACT: 

Joelle P. Justus, Esq., Office of the 

General Counsel, U.S. International 

Trade Commission, 500 E Street SW, 

Washington, DC 20436, telephone (202) 

205–2593. Copies of non-confidential 

documents filed in connection with this 

investigation may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. For help 

accessing EDIS, please email 

EDIS3Help@usitc.gov. General 

information concerning the Commission 

may also be obtained by accessing its 

internet server at https://www.usitc.gov. 

Hearing-impaired persons are advised 

that information on this matter can be 

obtained by contacting the 

Commission’s TDD terminal on (202) 

205–1810. 

SUPPLEMENTARY INFORMATION: The 

Commission instituted this investigation 

on May 31, 2023, based on a complaint, 

as supplemented, filed by Composite 

Resources, Inc. of Rock Hill, South 

Carolina, and North American Rescue, 

LLC of Greer, South Carolina 

(collectively, ‘‘Complainants’’). 88 FR 

34893–95 (May 31, 2023). The 

complaint, as supplemented, alleged 

violations of section 337 of the Tariff 

Act of 1930, as amended, 19 U.S.C. 

1337, in the importation into the United 

States, sale for importation, or sale in 

the United States after importation of 

certain blood flow restriction devices 

with rotatable windlasses and 

components thereof that infringe one or 

more of: claims 1–17 of the ’067 patent, 

claims 1–30 of the U.S. Patent No. 

8,888,807 (‘‘the ’807 patent’’), and 

claims 1–13 of the U.S. Patent No. 

10,016,203 (‘‘the ’203 patent’’); United 

States Trademark Registration Nos. 

3,863,064 and 5,064,378; and trade 

dress infringement in violation of 

Section 43(a) of the Lanham Act (15 

U.S.C. 1125) the threat or effect of 

which is to destroy or substantially 

injure an industry in the United States. 

Id. at 34893–94; see Complaint, ¶¶ 9–15. 

The complaint also requested the 

issuance of a GEO with respect to all of 

these allegations. 

The Commission’s notice of 

investigation named the following 

respondents: (1) Anping Longji Medical 

Equipment Factory of Hengshui City, 

China; Dongguanwin Si Hai Precision 

Mold Co., Ltd. of Dongguan, China; 

Eiffel Medical Supplies Co., Ltd. of 

Shenzhen, China; Empire State 

Distributors Inc. of Brooklyn, New York; 

EMRN Medical Equipment of LaSalle, 

Canada; GD Tianwu New Material Tech 

Co., Ltd. of Shawan Town, China; 

Hengshui Runde Medical Instruments 

Co., Ltd. of Hengshui City, China; 

Putian Dima Trading Co., Ltd. of Putian 

City, China; Rhino Inc. of Lewes, 

Delaware; Shanghai Sixu International 

Freight Agent Co., Ltd. of Shanghai, 

China; Shenzhen Anben E-Commerce 

Co., Ltd. of Shenzhen, China; Shenzhen 

TMI Medical Supplies Co., Ltd. of 

Shenzhen, China; Shenzhen Yujie 

Commercial and Trading Co., Ltd. of 

Shenzhen, China; Wuxi Emsrun 

Technology Co., Ltd. of Wuxi City, 

China; Wuxi Golden Hour Medical 

Technology Co., Ltd. of Wuxi City, 

China; and Wuxi Puneda Technology 

Co., Ltd. of Wuxi City, China 

(collectively, ‘‘the Defaulting 

Respondents’’); (2) Chaozhou Jiduo 

Trading Co., Ltd. of Chaozhou City, 

China; Dongguan Hongsui Electronic 

Commerce, Co., Ltd. of Dongguan City, 

China; Fuzhou Meirun Medical 

Equipment Technology Co., Ltd. of 

Fuzhou, China; Henan Eyocean EVerDate Sep<11>2014 17:26 Oct 03, 2024 Jkt 265001 PO 00000 Frm 00076 Fmt 4703 Sfmt 4703 E:\FR\FM\04OCN1.SGM 04OCN1

khammond on DSKJM1Z7X2PROD with NOTICES